Brandeis University, USA.
University of Massachusetts Medical School, USA.
Autism. 2020 Jan;24(1):177-189. doi: 10.1177/1362361319855795. Epub 2019 Jun 12.
A retrospective data analysis using 2004-2014 Healthcare Cost and Utilization Project Nationwide Inpatient Sample was conducted to examine in-hospital mortality among adults with autism spectrum disorders in the United States compared to individuals in the general population. We modeled logistic regressions to compare inpatient hospital mortality between adults with autism spectrum disorders (n = 34,237) and age-matched and sex-matched controls (n = 102,711) in a 1:3 ratio. Adults with autism spectrum disorders had higher odds for inpatient hospital mortality than controls (odds ratio = 1.44, 95% confidence interval: 1.29-1.61, p < 0.001). This risk remained high even after adjustment for age, sex, race/ethnicity, income, number of comorbidities, epilepsy and psychiatric comorbidities, hospital bed size, hospital region, and hospitalization year (odds ratio = 1.51, 95% confidence interval: 1.33-1.72, p < 0.001). Adults with autism spectrum disorders who experienced in-hospital mortality had a higher risk for having 10 out of 27 observed Elixhauser-based medical comorbidities at the time of death, including psychoses, other neurological disorders, diabetes, hypothyroidism, rheumatoid arthritis collagen vascular disease, obesity, weight loss, fluid and electrolyte disorders, deficiency anemias, and paralysis. The results from the interaction of sex and autism spectrum disorders status suggest that women with autism spectrum disorders have almost two times higher odds for in-hospital mortality (odds ratio = 1.95, p < 0.001) than men with autism spectrum disorders. The results from the stratified analysis also showed that women with autism spectrum disorders had 3.17 times higher odds (95% confidence interval: 2.50-4.01, p < 0.001) of in-hospital mortality compared to women from the non-autism spectrum disorders matched control group; this difference persisted even after adjusting for socioeconomic, clinical, and hospital characteristics (odds ratio = 2.75, 95% confidence interval: 2.09-3.64, p < 0.001). Our findings underscore the need for more research to develop better strategies for healthcare and service delivery to people with autism spectrum disorders.
采用 2004-2014 年医疗保健成本和利用项目全国住院患者样本进行回顾性数据分析,以研究与普通人群相比,美国自闭症谱系障碍成年人的住院死亡率。我们建立逻辑回归模型,以比较自闭症谱系障碍成年人(n=34237)与年龄和性别匹配的对照组(n=102711)在 1:3 比例下的住院医院死亡率。与对照组相比,自闭症谱系障碍成年人的住院医院死亡率更高(优势比=1.44,95%置信区间:1.29-1.61,p<0.001)。即使在调整了年龄、性别、种族/民族、收入、合并症数量、癫痫和精神共病、病床大小、医院区域和住院年份后,这种风险仍然很高(优势比=1.51,95%置信区间:1.33-1.72,p<0.001)。经历住院死亡的自闭症谱系障碍成年人在死亡时更有可能患有 27 种观察到的基于 Elixhauser 的合并症中的 10 种,包括精神病、其他神经障碍、糖尿病、甲状腺功能减退症、类风湿性关节炎胶原血管疾病、肥胖症、体重减轻、液体和电解质紊乱、贫血和瘫痪。性别和自闭症谱系障碍状况相互作用的结果表明,自闭症谱系障碍女性的住院死亡率几乎是自闭症谱系障碍男性的两倍(优势比=1.95,p<0.001)。分层分析的结果还表明,与非自闭症谱系障碍匹配对照组的女性相比,自闭症谱系障碍女性的住院死亡率高出 3.17 倍(95%置信区间:2.50-4.01,p<0.001);即使在调整了社会经济、临床和医院特征后,这种差异仍然存在(优势比=2.75,95%置信区间:2.09-3.64,p<0.001)。我们的研究结果强调需要开展更多的研究,为自闭症谱系障碍患者制定更好的医疗保健和服务提供策略。